A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
An Almost Normal Life Expectancy for People With HIV?
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Misleading News Reports Suggest HIV Cure Is Near
New HIV Drug Class Shows Promise
Gene Therapy Shows Promise in Controlling HIV
Potential Microbicide Tricks HIV Into Sudden Death
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

January 25, 2013

Stanford’s Gene Therapy Helps Block HIV’s Ability to Bind to CD4s

In a step forward for genetic therapy research, scientists at Stanford University School of Medicine have created an advanced method of engineering CD4 cells to resist HIV infection, the San Francisco Chronicle reports. Ongoing research conducted by Sangamo BioSciences and the University of Pennsylvania has used gene therapy to effectively block the CCR5 receptor on the surface of CD4 cells to which HIV latches in order to ultimately gain entry into the cell. Building on that model, the Stanford study has gone further by creating another splice in the CCR5 receptor’s DNA and adding two additional genes—a method known as stacking. Consequently, the total of three synthetic genes helped prevent HIV’s entry into the cells through either the CCR5 or CXCR4 receptors. Their results were published in the journal Molecular Therapy.

The researchers tested their gene therapy in a laboratory setting (not in humans), inserting one, two or all three of the genes into CD4 cells before exposing them to the virus. Those cells that were exposed to either one or two gene modifications were somewhat protected against infection. But those that received the triple modification had more than a 1,200-fold protection against HIV molecules that use the CCR5 receptor for entry—called being “CCR5-tropic”—and a 1,700-fold protection against the CXCR4-tropic viruses.

In a statement, Matthew Porteus, MD, an associate professor of pediatrics at Stanford, said such tailored gene therapy could one day replace daily antiretrovirals as a treatment for HIV. However, actual human trials aren’t expected for another five years.

To read the Stanford statement, click here.

To read the San Francisco Chronicle story, click here.

Search: Stanford Medical School, HIV, CD4, CCR%, CXCR4, Molecular Therapy, University of Pennsylvania, San Francisco Chronicle, Sangamo BioSciences, Matthew Porteus, receptor.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (15 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dversescott
    Baltimore
    Maryland


    juliar33
    brooklyn
    New York


    ernienyc
    Bronx
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Conference Coverage

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


20th Conference on Retroviruses and Opportunistic Infections
(CROI 2013)
Atlanta, GA
March 3 - 7, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.